智通财经网·2025-11-26 10:24Core Viewpoint - 康希诺生物 announced the cancellation of 406,100 shares from its repurchase account due to non-compliance with the intended use for employee stock ownership or equity incentives within the stipulated three-year period [1] Group 1: Company Actions - 康希诺生物's share repurchase was governed by relevant laws and regulations, including the Company Law of the People's Republic of China and the Shanghai Stock Exchange's guidelines [1] - The company is required to transfer repurchased shares for employee stock ownership or equity incentives within three years of repurchase [1] - As the company did not utilize all repurchased shares for the intended purposes, it will cancel the 406,100 shares and reduce its registered capital accordingly [1]